Budget Impact of Adaptive Abiraterone Therapy for Castration-Resistant Prostate Cancer.
Budget Impact of Adaptive Abiraterone Therapy for Castration-Resistant Prostate Cancer. is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Budget Impact of Adaptive Abiraterone Therapy for Castration-Resistant Prostate Cancer. have?
Budget Impact of Adaptive Abiraterone Therapy for Castration-Resistant Prostate Cancer. has 14 citations in the OpenAlex counts ScholarIQ stores.
When was Budget Impact of Adaptive Abiraterone Therapy for Castration-Resistant Prostate Cancer. published?
Budget Impact of Adaptive Abiraterone Therapy for Castration-Resistant Prostate Cancer. has 2021 year in the ScholarIQ index.
What is the open-access status of Budget Impact of Adaptive Abiraterone Therapy for Castration-Resistant Prostate Cancer.?
Budget Impact of Adaptive Abiraterone Therapy for Castration-Resistant Prostate Cancer. has green oa status in the ScholarIQ index.
What is the PMID of Budget Impact of Adaptive Abiraterone Therapy for Castration-Resistant Prostate Cancer.?
The PMID for Budget Impact of Adaptive Abiraterone Therapy for Castration-Resistant Prostate Cancer. is on the source record.
What is the OpenAlex record for Budget Impact of Adaptive Abiraterone Therapy for Castration-Resistant Prostate Cancer.?
The OpenAlex for Budget Impact of Adaptive Abiraterone Therapy for Castration-Resistant Prostate Cancer. is on the source record.